Ovarian Cancer

Ovarian Cancer is the leading cause of death from gynecologic cancers in the United States and is the fifth leading cause of cancer death among U.S. women.

Did you know?

The symptoms of Ovarian Cancer are often vague and subtle, making it difficult to diagnose. There is no 100% effective screening test for Ovarian Cancer but there are tests which may help when patients are at high risk or have early symptoms. In spite of this, patients are usually diagnosed in advanced stages and only 45% survive longer than five years. Only 19% of cases are caught before the cancer has spread beyond the ovary to the pelvic region. However, when ovarian cancer is detected and treated early on, the five-year survival rate is greater than 92%.

THERE IS NO 100% ACCURATE SCREENING TEST FOR OVARIAN CANCER.
THE PAP SMEAR DOES NOT TEST FOR OVARIAN CANCER.

Signs & symptoms

In the United States alone:

22K

New cases of Ovarian Cancer each year

45%

Late stage detection
will LIVE 5 years or more

186k

Living with Ovarian Cancer in the U.S.

92%

Early stage detection
or higher will LIVE

Prevention and risk reduction

Risk factors

Get tested annually

These tests do not always indicate ovarian cancer and can misrepresent a biological state. Talk to your doctor about your results.

Questions to ask

Speak to your gynecologist for more information and have an examination. Be sure to discuss the possibility of Ovarian Cancer with your doctor.

A vaginal-rectal pelvic examination (also called a bimanual exam) This exam allows the ovaries to be examined from many sides. Every woman should undergo a rectal and vaginal pelvic examination at her annual check-up with her gynecologist. Transvaginal Ultrasound This test uses sound waves to create a picture of the ovaries, and can often reveal if there are masses or irregularities on the surface of the ovaries. It cannot determine if you have cancer, but it can show characteristics that give different levels of suspicion.

CA125 blood test This test measures the level of a substance in the blood that may increase when a cancerous tumor is present; this protein is produced by Ovarian Cancer cells and is elevated in more than 80% of women with advanced Ovarian Cancers and 50% of those with early-stage cancers. Because CA125 misses half of early cancers and can be elevated by benign conditions, the National Cancer Institute (NCI) does not endorse using it to screen women at ordinary risk or in the general population.

It is very important to note that none of these tests are definitive when used on their own. They are most effective when used in combination with each other. The only way to confirm the presence of Ovarian Cancer suspected by the above tests is through a surgical biopsy of the tumor tissue.

The PAP test is used to detect cervical cancer, NOT Ovarian Cancer.

If tests suggest the possibility of Ovarian Cancer, seek a referral to a gynecologist or oncologist:

  • A gynecologic oncologist is a professional who specializes in treating women with reproductive tract cancers.
  • Gynecologic oncologists are initially trained as obstetrician/gynecologists and then undergo three to four years of specialized education in all of the effective forms of treatment for gynecologic cancers (surgery, radiation, chemotherapy and experimental treatments) as well as the biology and pathology of gynecologic cancers.

The importance of being treated by a gynecologic oncologist cannot be stressed enough. According to numerous medical studies, there are significant survival advantages for women who are treated, managed, and operated on by a gynecologic oncologist.

  • Surgery, debulking, and surgical staging (removal of ovarian tumors)
  • Chemotherapy
  • Radiation therapy when appropriate
  • Treatment for recurrent Ovarian Cancer needs to be determined by a gynecologic oncologist